Background: No systematic comparison has been conducted in Fiji using all suitable surveys of type 2 diabetes mellitus (T2DM) and obesity prevalence after standardizing methodology and definitions. Methods: Unit records from six surveys of Fiji adults were variously adjusted for age, ethnicity (Fiji Melanesians, i-Taukei, and Fijians of Asian Indian descent [Indians]) and urban-rural by sex to previous censuses. Trends were assessed using meta-regression (random effect models) and estimates projected to 2020. Poisson regression of strata was used to assess the effect of body mass index (BMI) increases on T2DM period trends. Results: Over 1980-2011, T2DM prevalence increased in i-Taukei men (3.2% to 11.1%; 1.32%/5 years) and women (5.3% to 13.6%; 1.40%/5 years) and Indian men (11.1% to 17.9%; 1.24%/5 years) and women (11.2% to 19.9%; 1.71%/5 years). Projected T2DM prevalence in 2020 is 13.3% and 16.7% in i-Taukei men and women, and 23.4% and 24.1% in Indian men and women, respectively. Obesity prevalence increased in i-Taukei men (12.6% to 28.9%; 2.99%/5 years) and women (30.1% to 52.9%; 3.84%/5 years) and in Indian men (2.8% to 9.4%; 1.21%/5 years) and women (13.2% to 26.6%; 2.61%/ 5 years). Projected obesity prevalence in 2020 is 34.0% and 60.0% in i-Taukei and women, and 11.4% and 31.0% in Indian men and women, respectively. After age-adjustment, an estimated 27%, 25%, 16% and 18% of the T2DM period trend is attributable to BMI in i-Taukei men and women and Indian men and women, respectively. Conclusions: Prevalence of T2DM in Fiji is projected to continue increasing, driven by rising obesity, with consequences for premature mortality and life expectancy.
Introduction
Globally, type 2 diabetes mellitus (T2DM) mortality rates have increased 20% between 1990 and 2010 (from 16 to 20/100 000), whereas cardiovascular disease mortality may be affected, in part, by changes in mortality coding, 2 but the increased prevalence of T2DM and its precursor risk factors, especially obesity, also likely play a significant role. An estimated 60%-80% of people with T2DM die of CVD 3, 4 because of accelerated atherosclerosis. 5 Studies in the UK 6 and Canada 7 show that the presence of T2DM shortens life expectancy by an estimated 5-13 years and increases the risk of CVD mortality 1.5-4.5-fold and all-cause mortality by 1.5-2.7-fold. 6, 8, 9 Obesity is the strongest and most prevalent risk factor for T2DM. Meta-analyses of cohort studies estimate the overall relative risk (RR) of T2DM in people with a body mass index (BMI) ≥30 kg/m 2 is 6.7-12.4 compared with those with a BMI <25 kg/m 2 . 10, 11 Women are at greater risk than men with the same level of obesity.
11
A recent systematic review of T2DM in Pacific Island countries and territories 12 reported difficulties in accurately monitoring T2DM trends over time, in large part due to the varying methodology, diagnostic criteria, and sample sizes used that make prevalence data incomparable. In Fiji, multiple cross-sectional surveys relevant to T2DM have been conducted over three decades, but differing survey methods and definitions of T2DM and obesity used have precluded estimation of accurate period trends using all available data. A 1980 population survey estimated respective rural and urban T2DM prevalence (age >20 years) to be 1.7% and 4.8% in i-Taukei men, 1.7% and 8.2% in i-Taukei women, 12.7% and 14.1% in Indian men, and 12.9% and 12.3% in Indian women (mean 8.3% for men and 8.8% for women). 13 Population-based World Health Organization (WHO) STEPwise approach to Surveillance (STEPS) surveys found the prevalence of T2DM to be 14% in 2002 and 16% in 2011, and the prevalence of obesity to be 26% in 2002 and 32% in 2011. 14, 15 The present study assessed comparable population measures of T2DM and obesity prevalence in Fiji from empirical population-based studies to produce period trends over three decades, as well as projections of obesity and T2DM to 2020.
Methods

Survey selection
A literature search using PubMed, Medline, and Google Scholar was conducted to identify population surveys that measured obesity and T2DM in Fiji. Secondary searching of bibliographies and review articles was also undertaken. Consultations with key informants in the Pacific, including the WHO, Fiji Ministry of Health, and the Secretariat of the Pacific Community, were conducted to identify further surveys and procure unpublished data. The criteria for inclusion in the present study were that surveys: (i) contain information on urban-rural residency, ethnicity, sex, age, anthropometric measures, blood or plasma glucose measures or HbA1c, or self-reported T2DM status that could be used to estimate T2DM prevalence; (ii) were designed to be nationally representative or could be adjusted to reflect national demographic characteristics; and (iii) comprise sufficient numbers to stratify by sex, ethnicity and urban-rural residency.
Thirteen cross-sectional population surveys were identified, six of which were selected for the present analysis, specifically the 1980 National Cardiovascular and Diabetes Survey (NCVDS; n = 3068), 13 the 1993 National Nutrition Survey (NNS; n = 4606), 16 the 2002 STEPS survey (n = 6788), 14 the 2004 NNS (n = 4276), 17 the 2009 Eye Health Survey (EHS; n = 1381), 18 and the 2011 STEPS survey (n = 2668). 15 In the present analysis, only subjects in the 25-64 year age range and those from the two major ethnicities in Fiji were included. The two major ethnicities are indigenous Melanesians, known as i-Taukei, and Fijians of Asian Indian descent (Indians), comprising 57% and 38%, respectively, of the population in the 2007 census. 19 The 'Other' ethnicity was not included in analyses because it is a heterogeneous group consisting of other Pacific Islanders, Europeans and Asians, and comprises only 5% of the total Fiji population (2007 census). 19 Of the seven surveys not included in the analyses, four were from the Naduri Longitudinal Nutrition and Health Surveys (1952, 1963, 1982 and 1994) . [20] [21] [22] These studies were a series of (approximately) decennial surveys conducted in one i-Taukei village (Naduri) and are not nationally representative, and the published results do not define T2DM. The 1962 study by Cassidy 23 involved a survey of a suburb in Suva (1000 Indians) and several villages in the Rewa Delta (1000 i-Taukei). Anthropometric measurements were not collected. Subjects were tested for glycosuria and T2DM status was confirmed with fasting venous (presumably plasma) glucose. Published results were ethnic specific, but not provided by sex or age.
A study by Russell-Jones et al. 24 surveyed only i-Taukei over 40 years of age from a suburb of Suva and several remote villages. Fasting blood was collected and participants were given a 2-h oral glucose tolerance test (OGTT) using a 75-g glucose load. However, T2DM was defined as 2-h plasma glucose of ≥10.0 mmol/L (current guidelines ≥11.1mmol/L).
25
Published results were stratified by sex and urban-rural residence, but not age specific, and the survey year was not reported in the 1990 published paper. 25 For the surveys not included, unsuccessful attempts were made to contact authors for unit records to enable adjustments for deficiencies in published tables. A 1983
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survey by Hoskins et al. 26, 27 was excluded because there were selection biases that could not be overcome through adjustments for this study, because no unit records were available. First, 'rural' villages were defined as being at least 8 km outside a major town. This suggests participants who lived within 8-16 km of a town could have been selected, in which case their residence is more likely to be peri-urban than rural. Second, screening was not based on a randomized household survey, but participants volunteered within selected villages. As a result, reported T2DM prevalence was unusually high, ranging from 18.3% to 39.5% between sexes and ethnicities.
Diabetes
Adjustments were undertaken to facilitate comparability of diagnosis of T2DM across surveys. For studies measuring blood glucose (1980, 2002, 2011) 28 Only subjects who reported they had fasted were included in analyses. Analyses of FPG included those on insulin or oral medication. An extended description of methods used to adjust T2DM estimates is provided in Appendix S1, available as Supplementary Material to this paper.
For each NNS, which recorded only self-reported T2DM status, a predictive model was derived from the 2002 STEPS (see Appendix S1). Type 2 diabetes mellitus (as defined by WHO/IDF; y-variable) was modeled with ethnicity, age, BMI, self-reported T2DM (1993 NNS), or self-reported T2DM and/or on medication (2004 NNS) for each sex to estimate the probability of T2DM for each respondent.
In the 2009 EHS, T2DM prevalence was assessed as HbA1c ≥6.5% and/or self-reported T2DM (medication usage was not captured in that survey). Because only subjects ≥40 years were surveyed, T2DM (and obesity) prevalences for age <40 years (by 5-year age group) were taken from the 2011 STEPS data, which showed similarities to the 2009 EHS for T2DM (and obesity) prevalences for those aged 40-64 years. Back-projection of diabetes (and obesity) prevalence in those <40 years of age using the most suitable regression functions yielded similar findings to those of the 2011 STEPS survey data.
Adiposity
All surveys used in the present study recorded anthropometric measurements and BMI was calculated as weight (kg)/height (m) squared. In the 1980 NCVDS, 1993 NNS, and 2011 STEPS surveys, weight and height were measured once. In the 2002 STEPS survey, BMI was calculated from the average of two height and one weight measurement, whereas in the 2004 NNS, BMI was calculated from the average of two height and two weight measurements. For the 2009 EHS survey, only BMI was supplied as part of the unit records. In all surveys, participants were categorized into the following groups: underweight (BMI <18.5 kg/m 2 ), normal weight (BMI between ≥18.5 and <25.0 kg/m 2 ), overweight (BMI between ≥25 and <30 kg/m 2 ), and obese (BMI ≥30 kg/m 2 ), in line with current recommendations from the WHO. 29 The current obesity cut-off point (BMI ≥30 kg/m 2 ) may not be suitable for non-Euorpids because of differing body (muscle : fat) compositions. For people of Pacific Islander descent, it has been suggested that obesity be defined as BMI >32 kg/m 2 , 30 and that for people of Asian descent obesity should be defined as BMI ≥25 kg/m 2 . 29 Consequently, the present study estimates obesity prevalence using these ethnic-specific cut-off points for comparison with the current standard definition.
Demographic adjustments
Adjustments were made to all surveys to reduce selection bias and improve representativeness in order to more accurately estimate population T2DM and obesity prevalences. The two STEPS surveys and two NNS were designed to be nationally representative based on the previous census, although differential non-response by age, sex, ethnicity and urban-rural residency meant that resultant samples were not completely representative. The 1980 NCVDS and the 2009 EHS were population based, although not designed to be nationally representative, but can be adjusted to the preceding census by age, ethnicity and urban-rural for each sex, as required. Prevalence rates were directly age standardized 31 to the most recent population census. Details of demographic adjustments are given in Appendix S1.
Trend analyses
A linear random-effects meta-regression model was used to analyse period trends. Each survey was weighted by the inverse of the SE in the meta-regression, and adjusted mean FPG and BMI, and diabetes and obesity prevalences, were fitted to estimate linear trends over time and predict the prevalence of T2DM and obesity in 2020 by sex and overall. A sensitivity analysis of T2DM trends from meta-regression was also conducted. The models were: (i) all six surveys; (ii) five surveys excluding the 2009 EHS (which used HbA1c for T2DM); and (iii) three surveys excluding the 2009 EHS and 1993 and 2004 NNS (from which T2DM was estimated from self-report of T2DM), that is only the 1980 NCVDS and 2002 and 2011 STEPS surveys were included. No sensitivity analysis was performed for obesity prevalence because adiposity was measured using the same method (height and weight) for all surveys.
Effects of age and BMI on T2DM trends
Because only the probability of T2DM was available for each record in the NNS, strata analysis of the combined data (n = 15 340) was undertaken using Poisson regression. Strata consisted of survey (six strata lines), urban/rural (two strata lines), ethnicity (two strata lines), sex (two strata lines) and age group (four strata lines), a total of 192 strata lines. Each stratum contained counts of T2DM and mean BMI. For the 1993 and 2004 NNS, where probability of T2DM was estimated (see above), the T2DM count was calculated by multiplying the population in each stratum by the T2DM probability. Each stratum in the matrix was then weighted for urban-rural residence, ethnicity, and age for each period and sex to the nearest previous census using stratum weights, as detailed in Appendix S1.
Poisson regression, using the log of the strata population as an offset, was used to analyse the effects of changes in age structure and increasing BMI on T2DM prevalences between 1980 and 2011. The T2DM count was modeled with period (Model 1), period and age (Model 2), and period, age and BMI (Model 3). The relative risk (RR) for T2DM in 2011 was compared with 1980 (reference) for each model. The difference in RR between Models 1 and 2 was calculated to determine the contribution of age to T2DM and obesity trends over 30 years. The difference in RR between Models 2 and 3 was calculated to determine the contribution of BMI to T2DM trend over 30 years, adjusting for age.
Data were analyzed using SAS 9.4 (SAS Institute, Cary, NC, USA), SPSS 22 (IBM, Armonk, NY, USA), and Excel (Microsoft, Redmond, WA, USA), and metaregression was performed using Comprehensive MetaAnalysis Software V2.0 (Biostat, Englewood, NJ, USA).
Results
Diabetes and FPG
Type 2 diabetes mellitus prevalence has increased across all ethnic, sex, and age groups (Tables 1-3; Fig. 1 ), with those of Indian descent and women having higher Ethnic-specific cut-off points for obesity were BMI >32 kg/m 2 (i-Taukei) or BMI ≥25 kg/m 2 (Indian).
Sex-specific ethnicity was adjusted for urban-rural residence and age. Sex-specific estimates were adjusted for urban-rural residence, ethnicity and age. National Fiji estimates were adjusted for urban-rural residence, ethnicity, sex and age. Test for trend was conducted using a linear random effects meta-regression model. Note, all trends are significant at P < 0.05, except type 2 diabetes mellitus prevalence in Indian men (P = 0.079).
prevalence and rates. The prevalence of T2DM is projected to reach 13.3% in i-Taukei men, 16.7% i-Taukei women, 23.4% Indian men, 24.1% Indian women, and 19.3% nationally by 2020. Age-specific trends in T2DM (Fig. 2) show higher rates of increase with increasing age, from 0.47%/5 years in those aged 25-34 years to 3.06%/5 years in those aged 55-64 years. Increases in T2DM prevalence and mean FPG for all subgroups were statistically significant at P < 0.05, except T2DM prevalence in Indian men (P = 0.08).
Obesity and BMI
Between 1980 and 2011, obesity prevalence and rates have increased in all population groups (Tables 1-3 ; Fig. 1 ). When ethnic-specific obesity cut-off points (i-Taukei BMI >32 kg/m 2 , Indian BMI ≥25 kg/m 2 ) were applied, the increase per 5 years was less for i-Taukei populations and greater in Indian populations. This is a reversal of the ethnicity-obesity relationship in Fiji using standard cut-off points. Based on trends from meta-regression, projected obesity prevalence for 2020 using standard cutoff points is estimated to be 34.0% in i-Taukei men, 60.0% in i-Taukei women, 11.4% in Indian men, 31.0% in Indian women, and 38.3% nationally. Projected obesity prevalence for 2020 using ethnic-specific cut-off points is estimated to be in i-Taukei men 20.9%, 44.9% in i-Taukei women, 49.4% in Indian men, 72.0% in Indian women, and 46.6% nationally. Age-specific trends in obesity (Fig. 2) show that the highest rate of increase per 5 years occurred in those aged 25-34 years (3.30%, 95% confidence interval [CI] 3.06-3.54%), followed by those aged Data were from the 1980 National Cardiovascular and Diabetes Survey (NCVDS; n = 3068), 13 1993 National Nutrition Survey (NNS; n = 4606), 16 2002 STEPS survey (n = 6788), 14 2004 NNS (n = 4276), 17 2009 Eye Health Survey (EHS; n = 1381), 18 and 2011 STEPS survey (n = 2668). 15 Estimates were weighted to the nearest previous census to improve representativeness, including adjustments for age group and urban-rural residence. Diabetes and obesity trends in Fiji S. LIN et al. 45 -54 years (3.21%, 95% CI 2.94-3.48%) and 55-64 years (2.58%, 95% CI 2.37-2.79%), with lowest rates in those aged 35-44 years (2.21%, 95% CI 1.95-2.48%). Increases in obesity prevalence and mean BMI for all subgroups were significant at P < 0.01.
Sensitivity analysis
The increases in linear trend of T2DM prevalence over the period using data for all six surveys was significant at P < 0.0001, except for Indian men (P = 0.079), who had the lowest rate of increase (Table 4 ). Exclusion of surveys that did not include measurement of blood glucose produced similar trends but with only one sexethnic group statistically significant (Table 4) .
Effects of age and BMI on T2DM increases
The unadjusted RR in i-Taukei men for T2DM in 2011 compared with 1980 (reference) was 3.68 (95% CI 2.05-6.52; P < 0.0001). The RR after adjusting for age was 3.56 (95% CI 1.99-6.32; P < 0.0001), which is 4% lower. For i-Taukei women, the unadjusted RR was 2.60 (95% CI 1.68-3.99; P < 0.0001); adjusting for age, it was 2.48 (95% CI 1.60-3.81; P < 0.0001), a reduction of 3%. The unadjusted RR in Indian men for T2DM in 2011 compared with 1980 was 1.51 (95% CI 1.09-2.08; P = 0.013); after adjusting for age, it was 1.24 (95% CI 0.90-1.71; P = 0.185), a reduction of 18%. For Indian women, the unadjusted RR was 1.78 (95% CI 1.28-2.48; P = 0.001) and after adjusting for age was 1.46 (95% CI 1.05-2.02; P = 0.027), a decline of 18%.
After adjusting for age and BMI, in i-Taukei men the RR was 2.59 (95% CI 1.43-4.62; P = 0.002), a decline of 27% compared with age adjustment only. For i-Taukei women, after adjusting for age and BMI, the RR was 1.87 (95% CI 1.20-2.91; P = 0.007), 25% less than when only age was adjusted. In Indian men, after adjusting for age and BMI, the RR was 1.05 (95% CI 0.75-1.45; P = 0.793), a 16% decline compared with adjustment for age only. After adjusting for age and BMI in Indian women, the RR was 1.20 (95% CI 0.86-1.68; P = 0.288), a decrease of 18% compared with age adjustment only. Data were from the 1980 National Cardiovascular and Diabetes Survey (NCVDS; n = 3068), 13 1993 National Nutrition Survey (NNS; n = 4606), 16 2002 STEPS survey (n = 6788), 14 2004 NNS (n = 4276), 17 2009 Eye Health Survey (EHS; n = 1381), 18 and 2011 STEPS survey (n = 2668), 15 Estimates were weighted to recent previous censuses to improve representativeness, including adjustments for age group and urban-rural residence. Sex-specific data were also adjusted for ethnicity. National data were adjusted for all listed variables. Diabetes and obesity trends in Fiji S. LIN et al.
Discussion
The prevalence of T2DM and obesity has increased across the two dominant population subgroups of Fiji, namely i-Taukei and Fijians of Indian descent. Distinct sex-and ethnic-specific patterns are evident. Type 2 diabetes mellitus is more prevalent in Indian populations than i-Taukei, and women have a higher prevalence of T2DM than men, with rates increasing over time in both ethnicities and sexes. Prevalences increased across all age groups, with the highest rate of increase in T2DM occurring in the oldest age group (55-64 years) and the highest rate of increase in obesity occurring in the youngest age group (25-34 years) . In 2011, one-third of all Fijians were obese, using standard cut-off points, with i-Taukei obesity prevalence in i-Taukei two-to threefold that of Indians. However, when using ethnic-specific cut-off points, obesity in 2011 in Indians is 1.6-2.7-fold higher than in i-Taukei. Approximately 15%-28% of the T2DM increase is attributed to increases in BMI.
The variations in T2DM diagnostic techniques and changing diagnostic thresholds over time have posed challenges in producing accurate T2DM period trends for Fiji. Prior to the advent of glucose meters, the standard measure of glucose concentration was plasma glucose from a centrifuged specimen of whole blood from a venepuncture. Changes in glucose meter calibration for fasting glucose from blood, and comparability of T2DM based on FBG measurements are also significant issues. Details of these changes are given in Appendix S1.
Sensitivity analyses show that rates of T2DM increase are similar and statistical power is retained when excluding the 2009 EHS, but excluding the EHS (2009) and both the 1993 and 2004 NNS results in loss of statistical significance for three of the sex × ethnic groups. The minimal changes in slope in the sensitivity analysis indicate that the logistic models used to impute T2DM prevalence in the 1993 and 2004 NNS from self-reported T2DM produced values consistent with estimates from surveys incorporating FPG for designation of T2DM. Inclusion of only three surveys (1980, 2002, 2011) produces similar but statistically non-significant trends in all population subgroups except i-Taukei men. Inclusion of all available surveys in the trend analysis also smooths variations in estimates from unmeasured or uncorrected biases and confounders, improving generalizability of trend estimates.
In analyses of concatenated surveys using Poisson regression (of strata), when adjusting for age alone there are small changes in the RR in i-Taukei by period, but a larger effect is seen after age adjustment in Indians, likely associated with out-migration of young adults in the most recent periods. 19, 32 Between 1976 and 2007, the proportion of Indians aged 25-34 years (of those aged 25-64 years) decreased from 43.5% to 34.5% for men and from 44.6% to 32.0% for women, and the proportion of those aged 55-64 years increased from 9.4% to 13.7% for men and from 9.2% to 15.3% for women. 19, 32 The RR for T2DM in 2011 compared with 1980, after adjusting for age and BMI compared with adjusting for age alone, declined by 28% in i-Taukei men, by 24% in i-Taukei women, by 15% in Indian men, and by 17% in Indian women. Such reductions are similar to those reported by studies in Mauritius 33 and Denmark, 34 which found T2DM increases to be partially or mostly attributable to increases in average population body weight. The lesser effect of BMI on T2DM increase in Indians compared with i-Taukei may be due to BMI being a poorer predictor of T2DM in people of Asian descent. Body mass index does not account for placement of body fat, which, in Indians, tends to be deposited around the abdomen. 35 Central adiposity is more highly correlated with T2DM risk than overall adiposity. 36, 37 Studies in Indian populations have suggested that other adiposity measures, such as waist-to-hip or waist-to-height ratios, are better predictors of T2DM than BMI. 38 The weaker association between T2DM and BMI in Indians may also be due to the high prevalence of T2DM. In Pima Indians 39 and Nauruans, 40 in whomT2DM prevalence is high, BMI was not found to be a strong independent predictor of T2DM across the range of BMI.
In the present study, using the standard definition of obesity, i-Taukei populations had twice the obesity as Indians, but Indians had more T2DM than i-Taukei. The higher genetic susceptibility of Indians to T2DM 41 can explain, in part, the relatively high prevalence in relation to low obesity prevalence, but it may also be attributed to the inappropriateness of the standard obesity definition for these populations. The current BMI threshold for obesity (BMI ≥30 kg/m 2 ) was derived from prospective studies in mostly Europid populations that assessed the relationship between obesity and mortality risk. 30 Crosssectional studies have shown that for equivalent levels of BMI, people of Pacific Islander descent have a lower proportion of body fat compared with Europids. 30, 42 It has been suggested that BMI categories for people of the Pacific should be increased (i.e. overweight begins at BMI ≥27 kg/m 2 and obesity at >32 kg/m 2 ) because at these BMI levels the proportion of body fat more closely approximates the Europid-based cut-off point.
Evidence from cohort and cross-sectional studies of Asian populations has shown susceptibility to CVD and T2DM, and a higher percentage of body fat than Europids at equivalent BMI. [43] [44] [45] This suggests that BMI risk thresholds for Asians should be lowered, that overweight should begin at BMI ≥23 kg/m 2 and obesity at ≥25 kg/m 2 . 30 Lack of long-term studies examining BMI and obesity-related mortality across ethnic groups has prevented these ethnic-specific cut-off points from being validated, recommended, or adopted more widely. 30 In the present study, when ethnic-specific obesity cut-off points were applied, Indians had twice the obesity prevalence as i-Taukei compared with using the current standard definition, which produced obesity prevalence in i-Taukei double that in Indians. Notably, the correlation of prevalences of T2DM and obesity in the present study was closer in each ethnicity using the ethnic-specific obesity cut-off points, suggesting that these thresholds may be more appropriate than (Europid) BMI based on current standard guidelines.
The 2002 14 and 2011 15 STEPS surveys adjusted their results to the nearest previous census, as was also done in the present study. Published estimates from these surveys compared with those found in the present study are similar, even though the definitions and analyses differ somewhat. The 2002 STEPS survey reported T2DM prevalence of 16.1%, 14 compared with 16.5% in the present study, and obesity prevalence was reported to be 25.6%, 14 compared with 25.1% in the present study. The 2011 STEPS reported T2DM to be 14.3%, 15 compared with 15.6% to the present study, and obesity prevalence of 32.0%, 15 compared with 32.2% in the present study. The present study is the first to ensure sufficient comparability of multiple cross-sectional studies to provide accurate time trends of T2DM and obesity in Fiji. The increasing BMI and number of people who are obese will continue to drive the T2DM and other noncommunicable disease burden of premature morbidity and mortality, especially in women, because their risk of T2DM is greater than that of men at the same level of obesity. 11 In Fiji, CVD and T2DM are already exerting an effect on life expectancy because premature adult mortality has increased, and Fijian life expectancy has not improved since 1985 in both sexes and ethnicities. 46, 47 The situation is worst in i-Taukei women, for whom recent evidence indicates life expectancy has decreased. 47 Reducing premature adult mortality and increasing life expectancy in Fiji will require a sustained effort in controlling and reducing population risk factors to halt the increase in T2DM and other obesity-related diseases.
